Calliditas Therapeutics AB Sponsored ADR Net Profit Margin 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR net profit margin from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-06-30 | $0.15B | $-0.05B | -30.67% |
| 2024-03-31 | $0.12B | $-0.05B | -41.13% |
| 2023-12-31 | $0.11B | $-0.05B | -39.47% |
| 2023-09-30 | $0.11B | $-0.04B | -35.96% |
| 2023-06-30 | $0.11B | $-0.03B | -23.21% |
| 2023-03-31 | $0.09B | $-0.04B | -39.78% |
| 2022-12-31 | $0.08B | $-0.04B | -51.25% |
| 2022-09-30 | $0.04B | $-0.07B | -168.29% |
| 2022-06-30 | $0.04B | $-0.07B | -171.79% |
| 2021-09-30 | $0.02B | $-0.05B | -226.09% |
| 2020-12-31 | $0.00B | $-0.05B | inf% |
| 2020-03-31 | $0.02B | $-0.01B | -25.00% |
